Drug Profile


Alternative Names: GNP; Xylentra

Latest Information Update: 27 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Issar Pharma
  • Class Anti-infectives; Peptides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Burn infections; Wound infections

Most Recent Events

  • 27 Apr 2016 Preregistration for Burn infections in India (Topical)
  • 27 Apr 2016 Preregistration for Wound infections in India (Topical)
  • 17 Jul 2015 Genopep is still in phase III development in India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top